SH3BGRL2 Activators
Chemical activators of SH3BGRL2 utilize various mechanisms to modulate its activity through phosphorylation, a process that typically regulates protein function. Phorbol 12-myristate 13-acetate (PMA) is one such activator that targets protein kinase C (PKC), leading to the phosphorylation of SH3BGRL2. The activation of PKC by PMA results in a cascade of phosphorylation events that culminate in the modulation of SH3BGRL2 activity. Forskolin operates through a different mechanism, by increasing intracellular cyclic AMP (cAMP) levels. Elevated cAMP activates protein kinase A (PKA), which in turn can phosphorylate SH3BGRL2. Similarly, Dibutyryl-cAMP (db-cAMP), a cAMP analog, directly stimulates PKA, resulting in the phosphorylation of SH3BGRL2. Ionomycin, by raising intracellular calcium levels, activates calcium/calmodulin-dependent protein kinases (CaMKs), which also target SH3BGRL2 for phosphorylation.
Other chemicals influence SH3BGRL2 activity by affecting the balance of phosphorylation and dephosphorylation. Anisomycin activates stress-activated protein kinases that phosphorylate SH3BGRL2. Calyculin A and Okadaic Acid both inhibit protein phosphatases, leading to an accumulation of phosphorylated proteins, including SH3BGRL2. Cantharidin similarly inhibits protein phosphatase 2A (PP2A), enhancing the phosphorylation state of SH3BGRL2. Conversely, compounds like Bisindolylmaleimide I, though typically a PKC inhibitor, can indirectly result in the activation of alternative kinases that may phosphorylate SH3BGRL2. Additionally, Epigallocatechin gallate and Staurosporine modulate kinase signaling pathways, though in less direct manners than other activators, contributing to the phosphorylation and consequent activation of SH3BGRL2. Lastly, Jaspakinolide stabilizes actin filaments, which can affect cellular signaling pathways leading to the modification of SH3BGRL2. Each of these chemicals, through their unique interactions with cellular enzymes and signaling pathways, can activate SH3BGRL2 by promoting its phosphorylation state.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate activates protein kinase C (PKC), which can lead to the phosphorylation of SH3BGRL2. Phosphorylation is a common post-translational modification that can activate proteins. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin elevates intracellular calcium levels, which can activate calcium/calmodulin-dependent protein kinases (CaMKs). These kinases can phosphorylate SH3BGRL2, resulting in its activation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP (db-cAMP) is a cAMP analog that activates PKA. Activation of PKA can lead to the phosphorylation and activation of SH3BGRL2. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate can influence kinase signaling pathways which are responsible for phosphorylating SH3BGRL2, thereby leading to its activation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases, which can phosphorylate SH3BGRL2, leading to its activation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, as an inhibitor of protein phosphatases, leads to an increase in the phosphorylation levels of proteins, including SH3BGRL2, leading to its activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid, another inhibitor of protein phosphatases, can cause hyperphosphorylation of SH3BGRL2, resulting in its activation. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine can activate kinases under certain conditions, which may lead to the phosphorylation and activation of SH3BGRL2. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Cantharidin inhibits protein phosphatase 2A (PP2A), causing an increase in protein phosphorylation, including that of SH3BGRL2, which activates the protein. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I, although a PKC inhibitor, can lead to the compensatory activation of other kinases that may phosphorylate and activate SH3BGRL2. | ||||||